Senior insider sale
Chief Commercial Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$234.5K
5.96K shares
What this filing means
WILEY MATTHEW T. plans to sell 5.96K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $234.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/25/2026ACC: 0001950047-26-009816
Officer· Chief Commercial Officer
Since Feb 2026
5.96K
Shares to sell
$234.5K
Approx. market value
3.10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Services Rendered
9/25/2026
3.10KTotal acquired3.10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/25/2026 | Restricted Stock Vesting Under a Registered Plan Services Rendered | 3.10K | — |
| Total | 3.10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.87K
Market value
$120.8K
6/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.10K
Market value
$113.8K
9/25/2026
Total
Units
5.96K
Value
$234.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2026 | 2.87K | $120.8K | — | Completed |
| Planned — Approximate Date | ||||
9/25/2026 | 3.10K | $113.8K | NASDAQ | Planned |
| Total | 5.96K | $234.5K | ||